TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 88 filers reported holding TRINITY BIOTECH PLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $271,000 | +16.8% | 20,475 | 0.0% | 0.31% | +13.3% |
| Q2 2016 | $232,000 | -2.9% | 20,475 | 0.0% | 0.27% | +20.0% |
| Q1 2016 | $239,000 | -0.8% | 20,475 | 0.0% | 0.22% | +12.5% |
| Q4 2015 | $241,000 | -38.2% | 20,475 | -40.0% | 0.20% | -35.7% |
| Q3 2015 | $390,000 | -36.7% | 34,125 | 0.0% | 0.31% | -10.9% |
| Q2 2015 | $616,000 | +2.3% | 34,125 | +9.2% | 0.35% | +11.1% |
| Q1 2015 | $602,000 | +10.1% | 31,261 | 0.0% | 0.31% | -21.5% |
| Q4 2014 | $547,000 | – | 31,261 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |